In September 2025, Medtronic announced it had received FDA approval and launched the Altaviva device, a minimally invasive implant designed to treat urge urinary incontinence by delivering automatic ...

Medtronic plc MDT recently received Food and Drug Administration (“FDA”) approval for the minimally invasive implantable tibial neuromodulation (ITNM) Altaviva device. The therapy is inserted near the ...

Bladder control problems affect an estimated 43 million – or one in six – U.S. adults. Of those, nearly 16 million people have urge urinary incontinence, a common symptom of overactive bladder (OAB) ...

The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks Bladder control problems affect an ...

Thank you for joining call showcasing the Altaviva device, which just secured FDA approval back on September 18. I want to remind everyone that today's event is being recorded, and a replay will be ...

Embrace Gynecology becomes the third IDE clinical study for Hugo RAS in the U.S., demonstrating Medtronic’s commitment to ...